04/19/2024
3:35 PM | Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
5:06 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
7:07 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
12:41 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:39 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
11:54 AM | Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:13 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/05/2024
7:15 PM | Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:17 PM | Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:19 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:22 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:23 PM | Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:06 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:08 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:10 PM | Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:46 AM | RTW INVESTMENTS, LP (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A | |
02/13/2024
2:41 PM | SANDS CAPITAL MANAGEMENT, LLC (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SC 13G | |
02/08/2024
2:49 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
9:18 AM | Ultragenyx Pharmaceutical (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/29/2024
2:26 PM | BlackRock Inc. (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A | |
01/08/2024
5:03 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:17 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2023
4:22 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
4:14 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
3:47 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2023
5:31 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
5:31 AM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
10/19/2023
3:45 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2023
6:49 PM | Ultragenyx Pharmaceutical (Subject)
| Form FWP | |
10/17/2023
3:13 PM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
10/16/2023
7:05 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
11:48 AM | Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/10/2023
11:50 AM | Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
1:15 PM | Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
1:16 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
12:33 PM | Ultragenyx Pharmaceutical (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
09/11/2023
12:52 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
7:00 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
4:01 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023
4:50 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
4:51 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
09/05/2023
5:43 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2023
7:15 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
7:15 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
3:23 PM | Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023
1:34 PM | Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
5:17 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
12:00 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2023
1:28 PM | Ultragenyx Pharmaceutical (Issuer)
WELCH DANIEL G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
1:29 PM | Dunsire Deborah (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
1:30 PM | NARACHI MICHAEL (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
1:30 PM | SULIMAN SHEHNAAZ (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
1:31 PM | Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
1:32 PM | Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
1:33 PM | Ray Amrit (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
3:33 PM | Ultragenyx Pharmaceutical (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/19/2023
12:54 PM | Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
3:38 PM | Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2023
7:15 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
7:09 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
1:16 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
6:05 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/04/2023
3:09 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2023
5:14 PM | Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/02/2023
5:18 PM | Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
